Prophecy Development Corp. (PRPCF) 3.2568

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prophecy Development Corp. (PRPCF) 3.2568 $PRPCF

Prophecy Voluntarily Delists from OTCQX
Filing Services Canada XHTML - Fri Jan 29, 1:13PM CST

PCY.TO: 4.30 (-0.20)

Prophecy Closes $200,000 Private Placement and Issues Shares for Debt
Filing Services Canada - Mon Jan 25, 1:04PM CST
Prophecy Closes $200,000 Private Placement and Issues Shares for Debt
PCY.TO: 4.30 (-0.20)

Prophecy Signs Non-Binding Joint Development Agreement with Chinese Partner to Invest in Chandgana Power Plant in Mongolia
Filing Services Canada - Tue Dec 22, 12:03PM CST
Prophecy Signs Non-Binding Joint Development Agreement with Chinese Partner to Invest in Chandgana Power Plant in Mongolia
PCY.TO: 4.30 (-0.20)

Prophecy Raised $250,000 in Private Placement Announced on November 12, 2015
Filing Services Canada - Fri Dec 18, 3:10PM CST
Prophecy Raised $250,000 in Private Placement Announced on November 12, 2015
PCY.TO: 4.30 (-0.20)

Prophecy Signs EPC and Equity Investment Agreements with China’s SEPCO2 for Chandgana Power Plant in Mongolia
Filing Services Canada XHTML - Fri Dec 18, 2:55PM CST

PCY.TO: 4.30 (-0.20)

Prophecy Signs EPC and Equity Investment Agreements with China's SEPCO2 for Chandgana Power Plant in Mongolia
Filing Services Canada - Fri Dec 18, 2:55PM CST
Prophecy Signs EPC and Equity Investment Agreements with Chinas SEPCO2 for Chandgana Power Plant in Mongolia
PCY.TO: 4.30 (-0.20)

Prophecy's Pulacayo Project Receives Toll Milling Offers
Marketwired - Tue Nov 24, 8:16AM CST
Prophecy Development Corp. ("Prophecy" or the "Company" (TSX: PCY)(OTCQX: PRPCF)(FRANKFURT: 1P2) is pleased to provide the following update on progress at its Pulacayo project:
PAAS: 18.78 (+0.13), PCY.TO: 4.30 (-0.20)

Prophecy Closes $250,000 First Tranche of Private Placement
Marketwired - Fri Nov 13, 10:15AM CST
Prophecy Development Corp. ("Prophecy" or the "Company" (TSX: PCY)(OTCQX: PRPCF)(Frankfurt: 1P2) announces that it has closed the first tranche of the $1,000,000 non-brokered private placement announced on November 12, 2015 (the "Placement".
PCY.TO: 4.30 (-0.20)

Prophecy Announces $1,000,000 Private Placement
Marketwired - Thu Nov 12, 1:43PM CST
Prophecy Development Corp. ("Prophecy" or the "Company" (TSX: PCY)(OTCQX: PRPCF)(FRANKFURT: 1P2) announces that it is undertaking a non-brokered private placement (the "Placement" involving the issuance of up to 25,000,000 units (each a "Unit" at a price of $0.04 per Unit. Each Unit will consist of one Common share in the capital of the Company (a "Share" and one Share purchase warrant (a "Warrant". Each Warrant entitles the holder to acquire an additional Share at a price of $0.07 per Share for a period of five years from the date of issuance.
PCY.TO: 4.30 (-0.20)

Prophecy Development Corp. files Technical Report for Mineral Resource Estimate for the Pulacayo Project's Paca Silver-Zinc-Lead Deposit
Marketwire Canada - Thu Nov 05, 5:25PM CST
Prophecy Development Corp. ("Prophecy" or the "Company" (TSXCY) (OTCQXRPCF) (FRANKFURT:1P2) is pleased to announce that it has filed a technical report prepared in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects ("NI 43-101" related to an independent mineral resource estimate for the Company's Paca silver-zinc-lead deposit, that was prepared in accordance with the CIM Definition Standards on Mineral Resources and Mineral Reserves (the "CIM Standards" referenced in NI 43-101 and announced in its news release issued on September 21, 2015. The Paca deposit is located in Bolivia, 7km north of Prophecy's Pulacayo deposit which is located, 107km northeast of Sumitomo Corporation's San Cristobal silver mine, 185km southwest of Coeur Mining, Inc.'s San Bartolome silver mine, and 139km north of Pan American Silver Corp.'s San Vicente silver mine.
PAAS: 18.78 (+0.13), PCY.TO: 4.30 (-0.20)

Prophecy Closes Private Placement Announced on September 1, 2015 With Gross Proceeds of $556,000
Marketwired - Wed Nov 04, 2:33PM CST
Prophecy Development Corp. ("Prophecy" or the "Company" (TSX: PCY)(OTCQX: PRPCF)(FRANKFURT: 1P2) announces the cancellation of the remainder of the proposed $2,000,000 private placement previously announced in its September 1, 2015 news release. The Company successfully raised gross cash proceeds of $556,000 through the issuance of 11,120,000 units of Prophecy as announced in its September 30, 2015 news release.
PCY.TO: 4.30 (-0.20)

Prophecy Closes $556,000 First Cash Tranche of Private Placement
Marketwired - Wed Sep 30, 10:30AM CDT
Prophecy Development Corp. ("Prophecy" or the "Company" (TSX: PCY)(OTCQX: PRPCF)(FRANKFURT: 1P2) announces that it has closed the first cash tranche of the non-brokered private placement announced on September 1, 2015 (the "Placement".
PCY.TO: 4.30 (-0.20)

Prophecy Reports 1.26 Million Tonnes of Inferred Resource Grading 444 g/t Ag Eq. (363 g/t Silver, 0.98% Zinc, 1.02% Lead) for Paca Deposit
Marketwired - Mon Sep 21, 6:31AM CDT
Prophecy Development Corp. ("Prophecy" or the "Company" (TSX: PCY)(OTCQX: PRPCF)(FRANKFURT: 1P2) is pleased to announce receipt of an independent mineral resource estimate for the Paca deposit, part of the Company's Pulacayo silver-zinc-lead project, prepared in accordance with the CIM Definition Standards on Mineral Resources and Mineral Reserves referenced in National Instrument 43-101, Standards of Disclosure for Mineral Projects ("NI 43-101". The effective date of the mineral resource estimate is September 9, 2015.
PAAS: 18.78 (+0.13), PCY.TO: 4.30 (-0.20)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 29

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 28

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 24

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 35

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 30

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 20

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Endava Investors: Legal Action Could Recover Your Losses

Updated Category News Views 87

Endava got tangled in a class action lawsuit over securities fraud back in 2024. Investors were already feeling the squeeze as whispers about declining demand for its services echoed through the trading floor. You know how it goes—when rumors hit, shares take a dive faster than you can blink. Class Action Reality: Who Gets to Play? The lawsuit targeted shareholders who...

Continue Reading
New Mortgage Ratings Assigned to Deephaven Trust Portfolio

Updated Category News Views 177

Introduction to Deephaven Residential Mortgage Trust 2024-1 In an important development within the non-prime mortgage market, KBRA has recently assigned preliminary ratings to eight classes of mortgage-backed notes from Deephaven Residential Mortgage Trust 2024-1 (DRMT 2024-1). This $514.6 million transaction comprises a unique pool of 1,330 residential mortgages,...

Continue Reading
Meta Platforms Declares Cash Dividend for Shareholders

Updated Category News Views 325

Quarterly Cash Dividend Announcement from Meta Platforms The board of directors of Meta Platforms, Inc. (NASDAQ: META) has recently declared a quarterly cash dividend of $0.525 per share, benefitting shareholders holding both Class A and Class B common stock. This dividend reflects the company's ongoing commitment to returning value to its shareholders. Dividend Payment...

Continue Reading
Campine Expects Strong Financial Upsurge in 2024 Performance

Updated Category News Views 125

Campine NV Forecasts Impressive Growth in 2024 Campine NV, a well-known name in the metals recycling and specialty chemicals sector, is gearing up for a promising financial year ahead. The company has recently indicated that it anticipates higher profits in 2024, thanks to favorable market conditions. Projected Revenue Growth for 2024 According to Campine's expectations,...

Continue Reading
Thumzup Media's Strategic Investment in Dogecoin Ahead of ETFs

Updated Category News Views 147

Thumzup Media's Strategic Move into Dogecoin Thumzup Media Corporation (Nasdaq: TZUP) has made headlines with its latest purchase of Dogecoin, securing around 7.5 million tokens valued at approximately $2 million. This significant acquisition marks the company's first open-market investment in Dogecoin, reflecting a strong belief in the digital currency's potential for...

Continue Reading